UAE: New unified card for people of determination to grant easier access to services
The new card is part of a larger collaboration between the Ministry of Family and the Zayed Higher Organisation for People of Determination. Through this joint initiative, the goal is to build a more inclusive, streamlined system that better serves the needs of PoD across the emirate.
Under this collaboration, both entities will work together to align legislation and regulations, standardise diagnostic and assessment procedures, and begin accepting card applications through the Zayed Higher Organization for Abu Dhabi residents. They also plan to launch joint training programmes and share expertise to improve the skills of professionals working in this sector.
In addition, they also plan a full implementation of the Unified National Disability Classification.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
In addition to streamlining access to services, the partnership will focus on protecting the rights of PoD, improving communication channels, and participating in local and international events.
Both entities also aim to develop smarter systems — like integrated data platforms and mobile apps — to ensure better service delivery.
Plans are also underway to upgrade care and rehabilitation centres, develop more inclusive educational curricula, and launch awareness campaigns to promote greater societal understanding.
Employment stability and professional empowerment for people of determination are also key priorities under the agreement.
'We see People of Determination as a cornerstone of our social fabric, fully entitled to their rights and eager to contribute meaningfully to their country's development. This collaboration with Zayed Higher Organization is an extension of the UAE's approach, which has turned inclusive support from a slogan into a living reality," said Hessa Abdulrahman Tahlak, assistant undersecretary for the Development Sector at the Ministry of Family.
"We are not merely providing services, we are building a humane and social system where difference becomes a driver for excellence and challenges a gateway to opportunities," she added.
Abdullah Al Humaidan, Secretary-General of the Zayed Higher Organisation, echoed this sentiment, calling the collaboration a strategic move toward delivering unified, efficient, and inclusive services.
He also highlighted the adoption of technology and digital integration to raise service efficiency and ensure full inclusion of PoD.
'We believe that creating an inclusive environment for People of Determination starts with effective institutional cooperation', Al Humaidan said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
a minute ago
- Khaleej Times
Dubai man undergoes complex awake brain surgery at NMC, recovers with renewed hope
What initially appeared to be fatigue gradually progressed to more serious neurological symptoms, prompting him to seek help at NMC's emergency department In a remarkable demonstration of advanced medical care and patient resilience, NMC Specialty Hospital, Al Nahda, Dubai, has successfully performed a high-precision awake brain surgery on a Dubai-based hotel employee, enabling his recovery from a complex brain tumour while preserving vital motor functions. Raymundo Omega, a long-time UAE resident and hospitality professional, began experiencing unexplained health concerns last year. What initially appeared to be fatigue gradually progressed to more serious neurological symptoms, prompting him to seek help at NMC's emergency department. Advanced diagnostic imaging revealed a lesion deep within the eloquent cortex of the right frontal lobe which a part of the brain that controls voluntary movement. While the imaging suggested it could be something serious, a tissue sample was needed to confirm exactly what it was and what the best form of treatment would be. Dr Sharath Kumar Maila, specialist neurosurgeon at NMC Specialty Hospital, Al Nahda, took on the complex case. "The tumour's location made surgery particularly challenging,' he explained. 'Our initial goal was to confirm the diagnosis through a biopsy. It was a very delicate process, as the lesion affected the motor cortex in areas that send signals to his muscles to move and areas which plan and coordinate complex movements before they are carried out (Brodmann areas 4 and 6). We had to meticulously plan the biopsy to avoid causing neurological issues. Using a robotic arm guided by neuronavigation, we safely obtained the tissue sample without any neurologic deficits.' The biopsy confirmed the tumour was a high-grade glioma and highly aggressive, so the goal was to remove as much of it as possible while keeping movement and muscle control intact. Given the tumour's location, an awake craniotomy or brain surgery while the patient remains awake was deemed the most effective and safest approach. During surgery, Omega remained conscious during critical phases, allowing surgeons to monitor real-time motor responses and map functional brain areas. 'We used a combination of real-time intraoperative ultrasound, fluorescence guidance, and neuronavigation, all working in tandem to guide the procedure,' Dr Sharath noted. The team achieved a significant tumour resection while preserving the patient's movement and functionality. Omega was able to walk immediately after surgery and was discharged in stable condition after four days in hospital. 'This was my first surgery, and I was initially very nervous,' said Omega. 'But the team at NMC Specialty Hospital, Al Nahda gave me the confidence to move forward. Their care and support were truly exceptional.' Omega is now undergoing postoperative therapy as part of a comprehensive, multidisciplinary care plan. His case underscores the importance of early intervention, technological innovation, and collaborative care in neurosurgical outcomes. 'When it comes to neurological tumours, timing is everything,' emphasised Dr. Sharath. 'Early diagnosis and timely surgical intervention can significantly influence recovery and long-term outcomes. At NMC, we remain committed to delivering patient-focused care using the latest advancements in medical technology.'
Zawya
24 minutes ago
- Zawya
Mediclinic City Hospital designated as a Centre of Excellence in Surgical Proctology
Dubai - Mediclinic City Hospital, located in Dubai Healthcare City (DHCC), announces its official designation as a Centre of Excellence in Surgical Proctology by the prestigious Surgical Review Corporation (SRC). This recognition underscores the hospital's unwavering commitment to delivering the highest standards in the diagnosis and treatment of colorectal, anal and pelvic floor disorders. This remarkable milestone was achieved under the leadership of Dr. Valentina Giaccaglia, Deputy Medical Director and Consultant Surgeon expert in Coloproctology and Pelvic Floor Diseases, who has also been honoured as the first female surgeon in the world to receive the SRC's Surgeon of Excellence in Surgical Proctology designation, a historic accomplishment and a testament to her work in the field. The Centre of Excellence status reflects the collective efforts of a dedicated multidisciplinary team, comprising colorectal surgeons, gastroenterologists, radiologists, pathologists, physiotherapists, anaesthesiologists, specialised nursing staff and administrative support. Their integrated approach ensures every patient benefits from comprehensive, personalised, and evidence-based care. Allae Almanini, Chief Operating Officer of Dubai Healthcare City Authority, said: 'We congratulate our strategic partner, Mediclinic City Hospital, for this notable recognition that underscores their persistent dedication to providing healthcare excellence and innovation. At DHCA, we are committed to fostering an enabling ecosystem where our partners can thrive, driving the advancement of high-quality, specialised healthcare services that enhance the well-being of community members across the UAE." 'This international recognition is a proud moment for Mediclinic City Hospital and the wider Mediclinic Middle East group,' said David Eglington, Hospital Director, Mediclinic City Hospital. 'It reflects the extraordinary commitment of Dr. Valentina and our multidisciplinary team to clinical excellence and innovation, and reinforces our position as a regional leader in specialised surgical care.' Dr. Valentina added: 'Being recognised as a Centre of Excellence is the result of years of dedication to improving outcomes and quality of life for patients. It is a privilege to work alongside such a skilled and compassionate team.' Mediclinic City Hospital remains committed to continuous improvement and delivering world-class outcomes by adhering to the highest international benchmarks. About Mediclinic Middle East: Mediclinic City Hospital provides international standard healthcare across a broad range of primary, secondary and tertiary services. It is operated by Mediclinic Middle East, which is part of Mediclinic Group, a diversified international private healthcare services group established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the UAE. The foundation of Mediclinic lies in the application of rigorous science to improve the lives of patients, through the use of state-of-the-art treatments and technologies to care for patients in an evidence-based environment. Mediclinic Middle East operates seven hospitals and 29 clinics with over 950 inpatient beds in the United Arab Emirates. About Dubai Healthcare City: Dubai Healthcare City (DHCC) was established in 2002 by His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and Ruler of Dubai. Governed by the Dubai Healthcare City Authority (DHCA), a Dubai Government entity, the free zone is Dubai's healthcare investment hub, attracting local and international investments to drive innovation and enhance healthcare delivery. The enabling healthcare and wellness destination is the largest healthcare ecosystem in the region, operating at the intersection of healthcare, wellness, community living, and regulation. DHCC also facilitates business set-up across medical care, wellness, academic and research, as well as hosting pharmaceutical, medical equipment, and support service providers. These offerings are complemented with a selection of modern lifestyle options, providing the community visitors with a wide range of hospitality and leisure features.
Al Etihad
an hour ago
- Al Etihad
Cleveland Clinic Abu Dhabi provides advanced first-of-its-kind stroke treatment in MENA region
19 Aug 2025 13:22 ABU DHABI (ALETIHAD)Cleveland Clinic Abu Dhabi has set a new standard in the treatment of brain aneurysms in the Middle East and North Africa (MENA) region, adopting the first Artisse Intrasaccular Flow Modulator in the region. Designated by the Department of Health – Abu Dhabi as a Centre of Excellence (CoE), this milestone underscores the hospital's position for stroke as it continues to advance medical technology and deliver world-class care for aneurysms, or stroke, occur when a weakened area in a blood vessel wall in the brain causes a bulge or balloon-like expansion, posing significant risks if untreated, including subarachnoid haemorrhage, a type of stroke caused by bleeding in the brain. Traditionally, treating aneurysms requires invasive open surgery. However, recent advancements in minimally invasive procedures have transformed how these conditions are managed, offering safer and more effective options for patients. Innovative Technique The procedure begins with a minimally invasive technique where a catheter is inserted through the patient's blood vessels, typically from the groin or arm, to reach the aneurysm in the brain. Using advanced 3D imaging and angiograms, physicians can visualise and assess the aneurysm with precision. Once positioned, the unique mesh device is deployed into the aneurysm and fills it, preventing blood from entering, reducing the risk of rupture and associated complications like subarachnoid haemorrhage. This innovative technique is particularly useful for aneurysms with wide necks, which are typically challenging to treat using traditional methods. The device stays in place permanently, eliminating the need for further invasive surgery while providing long-term protection against procedure itself can take between 2 and 8 hours, depending on the complexity of the aneurysm. Following the treatment, patients undergo follow-up imaging at regular intervals, typically at 3 and 6 months, to ensure the device is effectively treating the aneurysm. In the case of the first patient treated with this device at the Cleveland Clinic Abu Dhabi, follow-up imaging at 3 months showed successful occlusion of the aneurysm, demonstrating the promising potential of this innovative innovative technology marks a significant leap forward in cerebral aneurysm treatment. Unlike traditional methods that rely on multiple coils or filaments to occlude the aneurysm, this unique device uses a single, intricately designed mesh structure that effectively seals off the aneurysm, preventing blood flow and drastically reducing the risk of Fayeza Al Yafie, Executive Director of the Healthcare Quality Sector at the Department of Health – Abu Dhabi (DoH), said: 'Centres of Excellence in Abu Dhabi continue to affirm their commitment to enhancing the healthcare system by providing specialised care and utilising the emirate's advanced infrastructure. Abu Dhabi's dynamic regulatory environment encourages research and innovation in the continuous development and attraction of talent, as well as cutting-edge technologies and treatments that contribute to the health and safety of community members. We congratulate Cleveland Clinic Abu Dhabi on this milestone and look forward to working together to position the healthcare system in the emirate among the best and most intelligent globally.'Dr. Khalil Zahra, Staff Physician, Neurosurgery, Neurological Institute at Cleveland Clinic Abu Dhabi, said: "The introduction of the technology in our region not only enhances our ability to treat complex aneurysms but also demonstrates our ongoing commitment to bringing the latest medical advancements to our patients. This technology, combined with our multidisciplinary approach to patient care, ensures that we continue to provide world-class treatment options for even the most challenging neurological conditions. The successful implementation of the device in its first procedure marks a new era in the treatment of cerebral aneurysms, offering our patients a safer, more efficient, and less invasive treatment option."The adoption of the technology at Cleveland Clinic Abu Dhabi not only enhances current treatment options but also paves the way for future advancements in neurological Zahra said, 'This technology serves as a springboard for further innovation in our field. We anticipate that our experience with the new technology will inform future research initiatives, potentially leading to even more refined treatment methods for complex cerebrovascular conditions. Moreover, as we gather long-term data on patient outcomes, we expect to contribute valuable insights to the global neurosurgical community, further solidifying Cleveland Clinic Abu Dhabi's position as a leader in neurological care and research in the MENA region.'The successful implementation of the device at Cleveland Clinic Abu Dhabi is a testament to the Neurological Institute's comprehensive, multidisciplinary approach to care. By bringing together experts from various specialities, including neurosurgery, interventional neuroradiology, and neurology, this collaborative model ensures that each patient receives personalised treatment plans that leverage the full potential of cutting-edge technologies. As the designated Centre of Excellence for stroke, Cleveland Clinic Abu Dhabi was chosen as the launch site for this breakthrough device. The hospital remains at the forefront of neurological care in the MENA region, continuously seeking innovative solutions to improve patient outcomes and quality of life. The addition of the Artisse Intra-saccular Flow Modulator device to the hospital's treatment arsenal is yet another testament to its leadership in the field. Source: Aletihad - Abu Dhabi
